Orbital Kimura disease: maintenance therapy using mycophenolate mofetil
- 30 May 2024
- journal article
- research article
- Published by Taylor & Francis in Orbit
- Vol. 44 (2) , 215-222
Abstract
Kimura disease (KD) is a rare, chronic, inflammatory condition, predominantly found in male patients of Asian ethnicity. It typically presents between 50-60 years of age and usually with bilateral disease. Angiolymphoid hyperplasia with eosinophilia (ALHE) remains the main differential diagnosis, although histological analysis is essential in differentiating from other similarly presenting pathologies. In this case, we present an atypical case of unilateral orbital KD in a middle-aged, Caucasian, male gentleman and no evidence of regional lymphadenopathy along with a literature review of orbital KD and the differential diagnoses, histological features and management modalities available, adding to the sparse literature on the topic. At present, no recognised diagnostic criteria for KD are available, with histopathological analysis through incisional or excisional biopsy being the primary diagnostic method. Complete surgical excision with or without corticosteroid management remains the most common treatment modality although management is shifting to steroid-sparing immunomodulatory therapy. To the best of our knowledge, this is the first case to describe maintenance therapy of KD using mycophenolate mofetil.Keywords
This publication has 37 references indexed in Scilit:
- Clinical effects of dupilumab: A novel treatment for Kimura diseaseImmunity, Inflammation and Disease, 2023
- Tyrosine kinase inhibitors in osteosarcoma: Adapting treatment strategiesaJournal of Bone Oncology, 2023
- Treatment algorithm for Kimura's disease: A systematic review and meta-analysis of treatment modalities and prognostic predictorsInternational Journal of Surgery, 2022
- Warthin‐Finkeldey giant cells—A useful clue for the cytodiagnosis of Kimura disease: A report of three casesDiagnostic Cytopathology, 2020
- Langerhans-Cell HistiocytosisNew England Journal of Medicine, 2018
- Treatment of Kimura disease with mycophenolate mofetil monotherapyJAAD Case Reports, 2017
- Anti-IgE therapy to Kimura's disease: A pilot studyAuris Nasus Larynx, 2014
- Kimura?s disease presenting as bilateral parotid massesEuropean Archives of Oto-Rhino-Laryngology, 2004
- Mycophenolate mofetil as an immunomodulatory agent in the treatment of chronic ocular inflammatory disordersOphthalmology, 2003
- Kimura Disease of the Orbit and Ocular AdnexaSurvey of Ophthalmology, 1999